Investigation of Impact of AI on Prostate Cancer Workflow
for
Prostate Cancer, Prostatic Neoplasm, Cancer of the Prostate,
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 55 - 70+
Code: NCT07084779
Recruiting
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
for
Melanoma, Medullary Thyroid Cancer,
Location: Tucson AZ, Seattle WA
Sponsor: University of Arizona
Sex: All
Age: 18 - 70+
Code: NCT06814496
Phase1, Phase2, Recruiting
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
for
Metastatic Oral Cavity Carcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06997068
Phase2, Recruiting
Imaging of Solid Tumors Using 18F-TRX
for
Solid Tumor, Solid Carcinoma,
Location: San Francisco CA
Sponsor: Rahul Aggarwal
Sex: All
Age: 18+
Code: NCT06942104
Phase1, Recruiting
Interested in new pediatric cancer trials?
Get alerts for new trials in your area by subscribing now
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06910761
Phase2, Recruiting
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
for
Clinical Stage III Gastric Cancer AJCC v8,
Location: Houston TX
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06364410
Phase1, Recruiting
Prospective Registry of Histotripsy for Soft Tissue Tumors
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
for
Relapsed Pediatric ALL, Hematopoietic Cell Transplantation,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 21
Code: NCT07257419
Phase1, Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer